Integrated Core Strategies (US) LLC on COLL, Oct 8, 2026

Integrated Core Strategies (US) LLC now owns 7.4%, as a passive investor.

Date
Oct 8, 2026
Who
Integrated Core Strategies (US) LLC
Fund
COLL - Collegium Pharmaceutical
Stake
7.4% (2,400,985 shares)
Type of notice
Updated notice
Document number
0001104659-26-114760

Open the original document at the SEC →

We read this document automatically. If something looks wrong, the original is the one that counts.

Back to COLL